- ByInvesting.com-
Investing.com -- Deutsche Bank has overhauled its coverage of European chemicals and ingredients stocks, upgrading three companies...
Last | High | Low | |||||
|---|---|---|---|---|---|---|---|
| 260.40 | 262.00 | 256.80 | -1.60 | -0.61% | 40.56K | ||
| 80.45 | 80.85 | 79.25 | -0.10 | -0.12% | 33.87K | ||
| 103.10 | 104.20 | 102.30 | -0.90 | -0.87% | 439.37K | ||
| 26.58 | 26.86 | 25.90 | +0.48 | +1.84% | 457.58K | ||
| 76.20 | 76.90 | 75.75 | -0.40 | -0.52% | 102.15K | ||
| 252.00 | 254.80 | 245.20 | +0.70 | +0.28% | 292.98K | ||
| 59.02 | 59.32 | 58.20 | -0.40 | -0.67% | 1.64M | ||
| 61.75 | 61.75 | 60.90 | +0.40 | +0.65% | 425.37K | ||
| 16.04 | 16.50 | 15.93 | -0.33 | -2.02% | 635.18K | ||
| 68.25 | 68.55 | 67.45 | +0.05 | +0.07% | 123.47K | ||
| 126.60 | 130.80 | 124.60 | -2.90 | -2.24% | 151.35K | ||
| 9,570.0 | 9,710.0 | 9,420.0 | -100.0 | -1.03% | 520 | ||
| 50.95 | 52.55 | 50.55 | -2.05 | -3.87% | 53.6K | ||
| 63.50 | 64.10 | 63.20 | -0.80 | -1.24% | 39.14K | ||
| 207.80 | 220.20 | 207.80 | -10.80 | -4.94% | 60.86K | ||
| 22.14 | 22.26 | 21.82 | -0.14 | -0.63% | 400.9K | ||
| 158.40 | 159.10 | 156.60 | +1.60 | +1.02% | 53.76K | ||
| 607.40 | 613.80 | 600.00 | +5.60 | +0.93% | 137.13K | ||
| 8.26 | 8.28 | 8.10 | +0.03 | +0.36% | 495.68K | ||
| 49.00 | 49.87 | 48.16 | -0.27 | -0.55% | 280.27K |
Investing.com -- Deutsche Bank has overhauled its coverage of European chemicals and ingredients stocks, upgrading three companies...
Investing.com -- European pharma is back in focus as a must-own defensive sector, and Bernstein has made its picks clear. In a...
Investing.com -- China has emerged as a small net exporter of refined zinc after a spike in exports during the fourth quarter,...
Upcoming U.S. retail sales data is expected to influence market perceptions, building on a recent increase. Companies like Target...
After the Iran-Israel situation fizzled out for the time being, the Cboe Volatility Index (VIX) dropped from its yearly high of...
Dividend stocks can provide regular income and outperform the broader market. When building a dividend portfolio, investors should...
No Earning Reports have been scheduled